Mitochondrial uncouplers for treatment of metabolic diseases and cancer
US10227315B2 · kind B2 · utility
1Cited by
13References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2017 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | May 18, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6541
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to benzamide compounds, prodrugs of the compounds, pharmaceutical compositions containing the compounds and/or the prodrugs and methods of using the compounds, prodrugs and pharmaceutical compositions in the treatment of diseases related to lipid metabolism including diabetes, Non-Alcholic Fatty Liver Disease (NAFLD), Non-Alcholic Steathohepatitis (NASH), diseases caused by abnormal cell proliferation including cancer, psoriasis, and infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.